Publication | Closed Access

Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505

Lymphoid NeoplasiaSurgical OncologyMedicinePathologyPhase Ii StudyProphylactic UseMetronomic ChemotherapyOncologyRadiation OncologyCancer Research